Hot Paths

Haemonetics downgraded at Needham on vascular closure device competition

Press Room
Wall Street sign with American flag in the background, symbolizing the financial heart of New York.
  • Needham has downgraded Haemonetics (HAE) to hold from buy and removed its price target on concerns over increasing competition.
  • Analyst Mike Matson noted that Abbott (ABT) and privately held Cordis have newer venous closure devices.
  • Matson said that his checks
Exit mobile version